ArticleJournal for immunotherapy of cancer2022

Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.

Mi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.